Product Information
NIFEDIPINE ER 30 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1166 per EA under NDC 59651029501. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Jul 19, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651029501
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA213361FDA Approved
7/19/2021
TE Code
AB1
On Market Since
7/19/2021
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE ER 30 MG TABLET has been published 237 times since Mar 23, 2022, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1166 per EA |
|---|---|
| All-time high | $0.2036 (Apr 13, 2022) |
| All-time low | $0.0701 (Nov 20, 2024) |
| 52-week high | $0.1243 |
| 52-week low | $0.0952 |
| Median price | $0.1106 |
| Average price | $0.1137 |
| Largest weekly change | +52.5% (Aug 23, 2023) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nifedipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE ER 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE ER 30 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1166 per EA (NDC 59651029501), effective Sep 30, 2026.
How has the price of NIFEDIPINE ER 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE ER 30 MG TABLET has declined 42.7%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE ER 30 MG TABLET?
Since Mar 23, 2022, the NADAC for NIFEDIPINE ER 30 MG TABLET has ranged from a low of $0.0701 (Nov 20, 2024) to a high of $0.2036 (Apr 13, 2022), with a median of $0.1106 per EA.
Are there cheaper alternatives to NIFEDIPINE ER 30 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIFEDIPINE ER 30 MG TABLET, is $0.1006 per EA — about 14% below NIFEDIPINE ER 30 MG TABLET.
Who manufactures NIFEDIPINE ER 30 MG TABLET?
NIFEDIPINE ER 30 MG TABLET (NDC 59651029501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.